NCT00004192 2023-12-27Colony-Stimulating Factors to Relieve Neutropenia in Patients With Recurrent Non-Hodgkin's LymphomaUniversity of NebraskaPhase 2 Completed60 enrolled
NCT00007865 2023-12-27Combination Chemotherapy Plus Rituximab in Treating Patients With Recurrent or Refractory Non-Hodgkin's LymphomaUniversity of NebraskaPhase 2 Completed
NCT00080886 2023-10-06Rituximab, Carmustine; Cytarabine, Etoposide, & Melphalan; Stem Cell Transplantation for Non-Hodgkin's LymphomaUniversity of NebraskaPhase 2 Completed68 enrolled
NCT00691015 2017-06-28Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell TransplantBarbara Ann Karmanos Cancer InstitutePhase 2 Completed48 enrolled 12 charts
NCT00002880 2016-06-28Etoposide in Treating Patients With Relapsed Non-Hodgkin's LymphomaAlliance for Clinical Trials in OncologyPhase 2 Completed53 enrolled